“…However, most of these cases were reported from western countries, around 80% from Europe ( Uncini et al, 2020 ). Very limited data are available on SARS-CoV-2-associated GBS from low- and middle-income countries except four cases from India, one from Morocco and one from Sudan ( Hasan et al, 2020 ; Nanda et al, 2021 ; El Otmani et al, 2020 ; Sidig et al, 2020 ). About 80% previously reported cases had electro-diagnostic features of demyelinating GBS and 62% showed definite improvement after treatment with IVIg which is consistent with current findings ( Hasan et al, 2020 ; Uncini et al, 2020 ).…”